Illumina 二代測(cè)序組合試劑盒

"Illumina/TruSight RNA Fusion Panel Set B (48 samples)/RS-304-1003/1 Ea

" RS-304-1003 Illumina 產(chǎn)品編號(hào)： RS-304-1003美  元  價(jià)： $0.00會(huì)  員  價(jià)： 待定品       牌： Illumina產(chǎn)       地： 美國(guó)公       司： Illumina, Inc.產(chǎn)品分類： 其它>其它試劑>芯片公司分類： Clinical Research Products "Product Highlights:

This targeted RNA sequencing panel is a cost-effective solution to detect gene fusions in multiple cancer types, regardless of origin. Covering 507 fusion-associated genes, a single assay enables researchers to assess most known cancer-related fusions in blood, bone marrow, and FFPE samples, with the power to identify novel fusion gene partners.

Illumina 二代測(cè)序組合試劑盒

Industry-validated content for a comprehensive view of cancer-related fusion genes, detecting common and novel fusions

From RNA to results in 4 days including on-instrument software that displays fusion calls

Compatibility with desktop sequencers to maximize lab budgets

Optimized RNA sequencing for all sample types, including FFPE tissues

Simple Fusion Report for Customers New to NGS

On-instrument fusion calling provides NGS-based fusion detection to labs without additional bioinformatics support. The analysis provides a list of detected fusions, relevant disease associations (as identified by the Mitelman database), and evidence of fusion-supporting reads.

Robust, ReproducIBLe, and Low-Input Fusion Assay

This assay accommodates as little input as 20 ng FFPE RNA or 10 ng fresh-frozen total RNA. The TruSight RNA Fusion Panel provides a sensitive, reproducIBLe, and economical solution for studies of gene fusions in cancer research.

Specifications:

Assay Time 2.5 days

Hands-On Time 11 hours

Input Quantity 10 ng total RNA, 20–100 ng FFPE RNA

System Compatibility MiSeq,NextSeq 550,MiSeqDx in Research Mode,MiniSeq,NextSeq 500

Method Targeted RNA Sequencing,Sequencing for Cytogenomics

Variant Class Gene Fusions

Specialized Sample Types FFPE,Low Input

Technology Sequencing

Species Category Human

Cancer Type Pan-Cancer"

Illumina公司，致力于新一代測(cè)序和芯片技術(shù)的生產(chǎn)與開發(fā)，提供產(chǎn)品與應(yīng)用資訊

Illumina公司創(chuàng)立于1998年4月，是遺傳變異和生物學(xué)功能分析領(lǐng)域的優(yōu)秀的產(chǎn)品、技術(shù)和服務(wù)供應(yīng)商。通過(guò)幫助客戶加快實(shí)現(xiàn)生物信息的采集、分析和應(yīng)用，來(lái)改善人類健康。

Sequencing Kits/ Microarray Kits/Informatics Products/ Clinical Research Products/In Vitro Diagnostic/ Products/Molecular Biology Reagents/ Accessory Products

Illumina公司基因芯片、二代測(cè)序NGS測(cè)序儀及相關(guān)測(cè)序試劑盒等產(chǎn)品

咨詢illumina MiSeq測(cè)序試劑盒等產(chǎn)品歡迎您致電 上海易匯生物科技有限公司：1850 1609 238張經(jīng)理